NLSP
NASDAQ
NLS Pharmaceutics Ltd. - Ordinary Shares
Healthcare
· Pharmaceuticals
$0.76
-6.64 (-89.7%)
4
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$3.2M
ROE
3.9%
D/E
0.00
Beta
0.03
52W
$4–$47
Price Chart
Fundamentals Trend
| Metric | 2023-12-31 | 2024-06-30 | 2024-12-31 | 2025-09-02 | 2025-10-02 | 2025-11-03 |
|---|---|---|---|---|---|---|
| ROE (TTM) | — | — | 3.9% | 3.9% | 3.9% | 3.9% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 0.23 | 0.15 | 2.69 | 2.69 | 2.69 | 2.69 |
Key Ratios
ROA (TTM)
-115.6%
P/B
3.0
EPS (TTM)
$-1.91
CF/Share
$-0.84
52W High
$47.40
52W Low
$4.20
$4.20
52-Week Range
$47.40
How does NLSP compare to Pharmaceuticals peers?
Peer group: Micro-cap Pharmaceuticals (All) · 171 companies
NLSP valuation vs Pharmaceuticals peers
P/E ratio
—
▼
0%
below
peers
(22.4)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(5.0)
vs Peers
vs Industry
Overvalued
P/B ratio
3.0
▲
40%
above
peers
(2.1)
vs Peers
vs Industry
Pricier
Div yield
—
▼
0%
below
peers
(2.0%)
vs Peers
vs Industry
Low yield
NLSP profitability vs Pharmaceuticals peers
ROE
3.9%
▲
107%
above
peers
(-54.3%)
vs Peers
vs Industry
Top tier
Net margin
—
▼
0%
below
peers
(-47.4%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(68.3%)
vs Peers
vs Industry
In line
ROA
-115.6%
▼
209%
below
peers
(-37.4%)
vs Peers
vs Industry
Weak
NLSP financial health vs Pharmaceuticals peers
D/E ratio
0.0
▼
100%
below
peers
(1.5)
vs Peers
vs Industry
Low debt
Current ratio
2.7
▼
20%
below
peers
(3.4)
vs Peers
vs Industry
Below avg
Beta
0.0
▼
96%
below
peers
(0.9)
vs Peers
vs Industry
More volatile
NLSP fundamentals radar
NLSP
Peer median
Industry
NLSP profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
NLSP vs peers: key metrics
Latest News
No related news yet